TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32653029

Group type: EXPERIMENTAL
Intervention: INSPIRE intervention (Community Reinforcement and Family Training adapted for support persons) consisting of 10 rolling group sessions led by two facilitators.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care for patients on buprenorphine/naloxone.
Number of subjects: 0
Study: 36059921

Group type: EXPERIMENTAL
Intervention: Promethazine 12.5 mg and dexamethasone 8 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ondansetron 8 mg
Number of subjects: 70
Study: 32941872

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy for 23 months after 1 month of ticagrelor combined with aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dual antiplatelet therapy (DAPT) for 12 months
Number of subjects: 0
Study: 35790041

Group type: EXPERIMENTAL
Intervention: Anodal tDCS stimulation (2 mA for 20 minutes)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS stimulation (2 mA for 20 minutes)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS stimulation (control)
Number of subjects: 16
Study: 34647197

Group type: EXPERIMENTAL
Intervention: Coping and Promoting Strength (CAPS) program
Number of subjects: 136
Study: 32584909

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) model for predicting obstructive CAD
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) model for revascularization
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Invasive Coronary Angiography (ICA)
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Coronary Computed Tomographic Angiography (CCTA)
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Removal of imaging variables from ML model
Number of subjects: 1028
Study: 32930638

Group type: EXPERIMENTAL
Intervention: 4-week active program based on myofascial release and neurodynamics
Number of subjects: 40
Study: 34225686

Group type: EXPERIMENTAL
Intervention: Pramipexole in addition to mood stabilisers
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo in addition to mood stabilisers
Number of subjects: 290
Study: 35513882

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) with usual care
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 82
Study: 32193861

Group type: EXPERIMENTAL
Intervention: Watching real-time videos of colonoscopies (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Watching real-time videos of colonoscopies with detailed interpretations (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 0
Study: 33803576

Group type: EXPERIMENTAL
Intervention: 24-hour dietary recalls (24H FV)
Number of subjects: 177

Group type: COMPARATOR
Intervention: National Cancer Institute’s All‐Day Fruit and Vegetable Screener (NCI FV)
Number of subjects: 177
Study: 35785559

Group type: EXPERIMENTAL
Intervention: Needle acupuncture (10-week bilateral treatment of ST34, EX–LE12, and EX–LE8)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 60
Study: 34373044

Group type: EXPERIMENTAL
Intervention: safinamide (50 mg/day) for 3 months
Number of subjects: 30
Study: 32604381

Group type: EXPERIMENTAL
Intervention: Routine care (n = 128) with routine radiographs at 6 and 12 weeks
Number of subjects: 246

Group type: COMPARATOR
Intervention: Reduced-imaging group (n = 118) without routine radiographs at 6 and 12 weeks
Number of subjects: 246

Group type: COMPARATOR
Intervention: Reduced-imaging group
Number of subjects: 246

Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 246
Study: 35229713

Group type: EXPERIMENTAL
Intervention: Hip arthroscopy followed by postoperative physiotherapy
Number of subjects: 348

Group type: COMPARATOR
Intervention: Personalised hip therapy (individualised physiotherapist-led programme of conservative care)
Number of subjects: 348
Study: 33879328

Group type: EXPERIMENTAL
Intervention: Standard I COUGH education along with text message reminders to ambulate postoperatively
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard education alone
Number of subjects: 0
Study: 32743968

Group type: EXPERIMENTAL
Intervention: Dalla Bona attachments
Number of subjects: 24

Group type: COMPARATOR
Intervention: Locator attachments
Number of subjects: 24
Study: 35538242

Group type: EXPERIMENTAL
Intervention: Physical activity recommendation from the World Health Organization (PAR)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High-intensity interval training with whole-body electromyostimulation (HIIT + EMS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 66
Study: 33682457

Group type: EXPERIMENTAL
Intervention: Moderate protein intake (∼1.0 g·kg‐1·day‐1) during resistance training
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Higher protein intake (∼1.6 g·kg‐1·day‐1) during resistance training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both MOD and HIGH protein intake
Number of subjects: 50
Study: 32658754

Group type: EXPERIMENTAL
Intervention: National protocol: initial dose of 100 ml followed by 100 ml 6th hourly until 20WBCT was negative or 300 ml of ASV was given, whichever was earlier
Number of subjects: 140

Group type: COMPARATOR
Intervention: Current protocol: 70 ml followed by 30 ml every 6th hourly until two consecutive 20WBCT were negative
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: National ASV dosing protocol
Number of subjects: 140
Study: 36432526

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no substance ingestion)
Number of subjects: 20
Study: 32975705

Group type: EXPERIMENTAL
Intervention: Dentifrices containing 1100 ppm fluoride as NaF, 0.61% green tea extract, or 0.012% chlorhexidine digluconate
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Gels containing 400 μM EGCG, 0.012% chlorhexidine, 1 mM FeSO4, 1.23% F (NaF)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 23
Study: 34233094

Group type: EXPERIMENTAL
Intervention: Orthokeratology lenses (OKL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-vision spectacles (SVS)
Number of subjects: 60
Study: 34696742

Group type: EXPERIMENTAL
Intervention: Esketamine 28 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Esketamine 56 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 36261169

Group type: EXPERIMENTAL
Intervention: Computed tomography
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Invasive coronary angiography
Number of subjects: 3561
Study: 33606692

Group type: EXPERIMENTAL
Intervention: Probable common mental disorders (CMD)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hunger among those who reported intimate partner violence (IPV)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hunger among those who did not report IPV
Number of subjects: 220
Study: 32516291

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gliclazide 30 mg/day
Number of subjects: 44
Study: 36377016

Group type: EXPERIMENTAL
Intervention: Percutaneous radiologic gastrostomy (PRG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasal feeding tube (NFT)
Number of subjects: 60
Study: 32012166

Group type: EXPERIMENTAL
Intervention: Reciprocating single file followed by matching-taper single-cone filling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hand file and lateral compaction filling
Number of subjects: 120
Study: 35917508

Group type: EXPERIMENTAL
Intervention: PDT with 0.07% methylene blue as photosensitizer and laser irradiation (λ660 nm, power 40 mW, 5 min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (λ2940 nm, 15 Hz, 100 mJ)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Er:YAG laser + PDT
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2.5% sodium hypochlorite (NaOCl)
Number of subjects: 40
Study: 33151847

Group type: EXPERIMENTAL
Intervention: Immersive 360° video viewed through head-mounted displays (HMDs)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Immersive 360° video viewed through tablets
Number of subjects: 107
Study: 33070361

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe OSA
Number of subjects: 72
Study: 32727392

Group type: EXPERIMENTAL
Intervention: Support from nephrologists (co-management by primary care physicians and nephrologists)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Managed by primary care physicians with written instructions and nephrology consultations on demand
Number of subjects: 242
Study: 35531644

Group type: EXPERIMENTAL
Intervention: Smartphone Fundoscopy (SF)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Non-mydriatic Fundus Photography (NMFP)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Routine Fundoscopic Practice (Control)
Number of subjects: 79
Study: 32350320

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham-TENS
Number of subjects: 59
Study: 33413320

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus SP1)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: All groups (including Probiotics, Azithromycin, and Placebo)
Number of subjects: 47
Study: 36209081

Group type: EXPERIMENTAL
Intervention: nabiximols
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: counselling attendance
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: higher dose of nabiximols
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: longer duration of regular cannabis use
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: greater quantity of cannabis use
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: greater pain at baseline
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: more severe sleep issues
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: males
Number of subjects: 128
Study: 33390421

Group type: EXPERIMENTAL
Intervention: Intensive exercise plus 5 mg (up to 10 mg) of dapagliflozin daily (IT group)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Dapagliflozin alone (CT group)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Intensive exercise plus dapagliflozin (IT group)
Number of subjects: 146
Study: 35147302

Group type: EXPERIMENTAL
Intervention: 3.6 g/day n‐3‐PUFA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32757287

Group type: EXPERIMENTAL
Intervention: True NIAPs
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham NIAPs
Number of subjects: 56
Study: 33675013

Group type: EXPERIMENTAL
Intervention: Home-based strength exercise (twice weekly for 10 weeks) with educational materials, exercise equipment (dumbbells, resistance bands), and video coaching support.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention).
Number of subjects: 40
Study: 32978076

Group type: EXPERIMENTAL
Intervention: Clarithromycin-naproxen-oseltamivir combination therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Oseltamivir alone
Number of subjects: 54
Study: 36455504

Group type: EXPERIMENTAL
Intervention: FTD/TPI (35 mg/m2 twice daily days 1‐5 and 8‐12, 28‐day cycle)
Number of subjects: 868

Group type: EXPERIMENTAL
Intervention: FTD/TPI
Number of subjects: 868

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 868
Study: 32479701

Group type: EXPERIMENTAL
Intervention: Vitamin D insufficient (25(OH)D <50nmol/L)
Number of subjects: 851

Group type: COMPARATOR
Intervention: Vitamin D sufficient (25(OH)D ≥50nmol/L)
Number of subjects: 851
Study: 36352326

Group type: EXPERIMENTAL
Intervention: One-page educational graphic providing facts and benefits regarding COVID-19 vaccination
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Non-intervention group (control)
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Higher MMI scores
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: GAD-7 and PHQ-8 scores
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Psychiatric treatment initiation after March 2020
Number of subjects: 1103
Study: 33452295

Group type: EXPERIMENTAL
Intervention: beta-blocker (timolol maleate) and/or prostaglandin analog (latanoprost)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 151
Study: 35065786

Group type: EXPERIMENTAL
Intervention: Multifaceted educational programme including education about root-cause analysis and care bundles (4-month duration)
Number of subjects: 3454

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3454
Study: 32815991

Group type: EXPERIMENTAL
Intervention: Laparoscopic total gastrectomy (LTG)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Open total gastrectomy (OTG)
Number of subjects: 227
Study: 33998053

Group type: EXPERIMENTAL
Intervention: Proposed Mendelian randomization method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wald method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage predictor substitution (2SPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage residual inclusion (2SRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generalized method of moments (GMM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ever smoking
Number of subjects: 0
Study: 32937008

Group type: EXPERIMENTAL
Intervention: Continuation of ACEI or ARB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withdrawal of ACEI or ARB
Number of subjects: 0
Study: 35701454

Group type: EXPERIMENTAL
Intervention: wMel Wolbachia intervention in Aedes aegypti mosquito population
Number of subjects: 318

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: wMel Wolbachia intervention
Number of subjects: 318
Study: 34028647

Group type: EXPERIMENTAL
Intervention: Nomogram model based on routine biochemical variables including female gender, serum potassium, serum calcium-phosphorus product, and urine pH.
Number of subjects: 806

Group type: COMPARATOR
Intervention: Other known prediction models (control group).
Number of subjects: 806
Study: 36069505

Group type: EXPERIMENTAL
Intervention: 5 ml ropivacaine 0.5%
Number of subjects: 32

Group type: COMPARATOR
Intervention: 20 ml ropivacaine 0.5%
Number of subjects: 32
Study: 33947390

Group type: EXPERIMENTAL
Intervention: pemafibrate 0.1 mg/day
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: pemafibrate 0.2 mg/day
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: pemafibrate 0.4 mg/day
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: pemafibrate (all doses)
Number of subjects: 1253

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1253
Study: 32935191

Group type: EXPERIMENTAL
Intervention: Donor-to-recipient gender mismatched (male donor to female recipient)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Matched patients
Number of subjects: 546
Study: 33250209

Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: Eptinezumab 300 mg
Number of subjects: 888

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: Eptinezumab (all doses)
Number of subjects: 888
Study: 33054635

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with restricted calorie diet (RCD) for 12 weeks
Number of subjects: 62
Study: 33327340

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA), administered 2 times a week for 4 weeks.
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (specific intervention not detailed in the abstract).
Number of subjects: 112
Study: 35749925

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 99
Study: 34714398

Group type: EXPERIMENTAL
Intervention: White-opaque flowable composite liner
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tooth-colored composite (control)
Number of subjects: 100
Study: 33528372

Group type: EXPERIMENTAL
Intervention: Online tutorial (OT) only group
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Online tutorial plus motivational interviewing (OT-MI) group
Number of subjects: 624

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 624
Study: 32266988

Group type: EXPERIMENTAL
Intervention: PRIRATE 2020 guidelines implementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35705390

Group type: EXPERIMENTAL
Intervention: Phone recruitment strategy
Number of subjects: 1624

Group type: EXPERIMENTAL
Intervention: Email recruitment strategy
Number of subjects: 1624

Group type: EXPERIMENTAL
Intervention: Text message recruitment strategy
Number of subjects: 1624

Group type: EXPERIMENTAL
Intervention: Parents of girls
Number of subjects: 1624
Study: 34111865

Group type: EXPERIMENTAL
Intervention: Plastic cannulae
Number of subjects: 90

Group type: COMPARATOR
Intervention: Metal needles
Number of subjects: 90
Study: 36103719

Group type: EXPERIMENTAL
Intervention: Electrical vestibular stimulation (n=15) administered for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo stimulation (Control group, n=15)
Number of subjects: 30
Study: 34386216

Group type: EXPERIMENTAL
Intervention: Topical emollient therapy with sunflower seed oil (SSO)
Number of subjects: 20
Study: 32726666

Group type: EXPERIMENTAL
Intervention: Active intermittent theta burst stimulation (iTBS) over dorsomedial prefrontal cortex (dmPFC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham intermittent theta burst stimulation (iTBS)
Number of subjects: 30
Study: 35091522

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 34629300

Group type: EXPERIMENTAL
Intervention: Docetaxel + Metformin (D+M)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Docetaxel + Placebo (D+P)
Number of subjects: 99
Study: 35460929

Group type: EXPERIMENTAL
Intervention: PT-CY/BEN
Number of subjects: 13
Study: 33321381

Group type: EXPERIMENTAL
Intervention: Lurasidone (20-120 mg/day)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 413
Study: 35797166

Group type: EXPERIMENTAL
Intervention: Mindfulness practice
Number of subjects: 173

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 173
Study: 34422293

Group type: EXPERIMENTAL
Intervention: Team sport participation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Group circuit training
Number of subjects: 128
Study: 32669161

Group type: EXPERIMENTAL
Intervention: Domestic caffeine citrate
Number of subjects: 98

Group type: COMPARATOR
Intervention: Imported caffeine citrate
Number of subjects: 98
Study: 33688928

Group type: EXPERIMENTAL
Intervention: Lower expression of the angiotensin-converting enzyme (ACE) gene in blood
Number of subjects: 40675

Group type: EXPERIMENTAL
Intervention: ACE expression in prefrontal cortex
Number of subjects: 40675

Group type: EXPERIMENTAL
Intervention: ACE protein levels in cerebral spinal fluid
Number of subjects: 40675

Group type: EXPERIMENTAL
Intervention: ACE protein levels in plasma
Number of subjects: 40675

Group type: EXPERIMENTAL
Intervention: Lower systolic blood pressure associated with lower ACE expression
Number of subjects: 40675
Study: 32825565

Group type: EXPERIMENTAL
Intervention: Prototypes of Tobacco Users Scale (POTUS) for cigarette smokers
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Prototypes of Tobacco Users Scale (POTUS) for e‐cigarette users
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Negative prototypes at baseline
Number of subjects: 1414
Study: 35323085

Group type: EXPERIMENTAL
Intervention: Triptorelin (0.1 mg subcutaneous GnRH agonist)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (no luteal phase support)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Triptorelin with ovarian stimulation using letrozole
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Triptorelin with gonadotrophin added to letrozole
Number of subjects: 163
Study: 34493977

Group type: EXPERIMENTAL
Intervention: Ultraearly rehabilitation program (started within 72 hours of onset)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Early rehabilitation program (started from 72 hours to 7 days after onset)
Number of subjects: 86
Study: 35551165

Group type: EXPERIMENTAL
Intervention: FRT with a customized knee BRACE
Number of subjects: 30

Group type: COMPARATOR
Intervention: TARGET MATCH condition (no resistance applied)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FRT with elastic BAND
Number of subjects: 30
Study: 34087831

Group type: EXPERIMENTAL
Intervention: Continuous infusion of dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous infusion of 0.9% sodium chloride solution (control)
Number of subjects: 0
Study: 32799649

Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance approach™ (CO‐OP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional occupational therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CO‐OP
Number of subjects: 12
Study: 35264213

Group type: EXPERIMENTAL
Intervention: Green-MED diet (supplemented with 28g/day walnuts, daily polyphenol-rich green tea, and Mankai aquatic plant)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: MED diet (supplemented with 28g/day walnuts)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Healthy dietary guidelines (standard science-based nutritional counseling)
Number of subjects: 294
Study: 35614514

Group type: EXPERIMENTAL
Intervention: Shamiri Intervention
Number of subjects: 432

Group type: COMPARATOR
Intervention: Study-skills active control
Number of subjects: 432
Study: 33186897

Group type: EXPERIMENTAL
Intervention: Collagen Peptides (15 g/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33725433

Group type: EXPERIMENTAL
Intervention: High oxygen concentration (100% O2, non-rebreather mask, 8 L/min)
Number of subjects: 30
Study: 33843593

Group type: EXPERIMENTAL
Intervention: Gamified digital app with social support features
Number of subjects: 298

Group type: COMPARATOR
Intervention: Basic digital app with self‐monitoring and goal setting (Control)
Number of subjects: 298